Nonalcoholic Fatty Liver (NAFL): Overview; Role of Leptin in Pathogenesis of NASH; Zone 3 Predominance of Histopathological Features in Nonalcoholic Steatohepatitis; Genetic Background of Japanese Patients with Nonalcoholic Steatohepatitis (NASH); Predictors of Nonalcoholic Steatohepatitis in Japanese Patients: Thioredoxin and NASH; Clinical Features of Patients with Nonalcoholic Fatty Liver Disease; Pathogenesis and Significance of Restricted Diet and Exercise Therapy in Nonalcoholic Steatohepatitis (NASH); Mammalian Target of Rapamycin (mTOR); Effect of Oral Supplementation with Branched-Chain Amino Acids on Albumin Concentration in the Early Stage of CirrhosisNutritional Therapy in Patients with Liver Cirrhosis
Summary
"This collection of research and clinical findings on nonalcoholic steatohepatitis (NASH) and nutritional therapy contains significant new findings in several fields. As NASH frequently causes liver cirrhosis, the nutritional aspects of its treatment are discussed. Other areas covered include nonalcoholic fatty liver, the role of leptin in the pathogenesis of NASH, restricted diets and exercise therapy, mammalian targets of the peptide rapamycin, and genetic factors influencing the developments of NASH. This book is intended to be of particular relevance to researchers and those practicing in the field."--Jacket
